Abstract
Progranulin (GRN) gene variability has been analyzed in a sample of 354 patients with multiple sclerosis (MS) compared with 343 controls. No significant differences were observed, but by stratifying according to MS subtypes, a significant increased frequency of the rs2879096 TT genotype was found in primary progressive MS (PPMS) patients versus controls (16.0 vs 3.5%, P=0.023, odds ratio (OR) 5.2, 95% confidence interval (CI) 1.2–21.4). In addition, in PPMS, an association with the C allele of rs4792938 was observed (55.3 vs 33.5%, P=0.011, OR 2.4, 95% CI 1.2–4.7). An independent population was studied as replication, failing to confirm results previously obtained. Stratifying according to gender, an association with rs4792938 C allele was found in male PPMS patients compared with controls (40.7 vs 26.9%, P=0.002, OR 1.87, 95% CI 1.2–2.8). An association with the rs2879096T allele was observed (29.2 in patients compared with 18.9% in controls, P=0.012, OR 1.77, 95% CI 1.1–2.8). Haplotype analysis showed that TC haplotype frequency is increased in PPMS male patients compared with male controls (25.7 vs 16.6%; P=0.02, OR 1.69, 95% CI 1.1–2.7), whereas the respective GC haplotype seems to exert a protective effect, as its frequency is decreased in patients compared with controls (55.8% vs 70.9%; P=0.001, OR 0.52, 95% CI 0.4–0.8). Therefore, GRN haplotypes likely influence the risk of developing PPMS in males.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916–919.
Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442: 920–924.
Malaspina A, Kaushik N, de Belleroche J . Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 2001; 77: 132–145.
Johnston C, Jiang W, Chu T, Levine B . Identification of genes involved in the host response to neurovirulent alphavirus infection. J Virol 2001; 75: 10431–10445.
Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP-43-positive frontotemporal dementia. Human Mol Genet 2008; 17: 3631–3642.
Galimberti D, Fenoglio C, Cortini F, Serpente M, Venturelli E, Villa C et al. GRN variability contributes to sporadic frontotemporal lobar degeneration. J Alzheimers Dis 2010; 19: 171–177.
Rollinson S, Rohrer JD, van der Zee J, Sleegers K, Mead S, Elgelborghs S et al. No association of PGRN 3′UTR rs5848 in frontotemporal lobar degeneration. Neurobiol Aging 2009, (e-pub ahead of print).
Brouwers N, Sleegers K, Engelborghs S, Maurer-Stroth S, Gijselinck J, van der Zee J et al. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology 2008; 71: 656–664.
Sleegers K, Brouwers N, Maurer-Stroth S, van Es MA, Van Damme P, van Vught PWJ et al. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology 2008; 71: 253–259.
Nuytemans K, Pals P, Sleegers K, Engelborgghs S, Corsmit E, Peeters K et al. Progranulin variability has no major role in Parkinson disease genetic etiology. Neurology 2008; 71: 1147–1151.
Piccio L, Rossi B, Scarpini E, Laudanna C, Giagulli C, Issekutz AC et al. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric Gi-linked receptors. J Immunol 2002; 168: 1940–1949.
Galimberti D, Bresolin N, Scarpini E . Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments. Expert Rev Neurotherapeutics 2004; 4: 439–453.
Pirko I, Lucchinetti CF, Sriram S, Bakshi R . Gray matter involvement in multiple sclerosis. Neurology 2007; 68: 634–642.
Anderson JM, Patani R, Reynolds R, Nichola R, Compston A, Spillantini MG et al. Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis. Acta Neuropathol 2009; 117: 583–589.
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225–2229.
Patsopoulos NA, Tatsioni A, Ioannidis JP . Claims of sex differences: an empirical assessment in genetic associations. JAMA 2007; 298: 880–893.
Trapp BD, Nave K . Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008; 31: 247–269.
Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998; 280: 1610–1613.
Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, Li C et al. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosi 1998; 18: 1953–1962.
Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 2003; 33: 366–374.
McDonnell GV, Hawkins SA . Primary progressive multiple sclerosis: increasing clarity but many unanswered questions. J Neurol Sci 2002; 199: 1–15.
Filippi M, Campi A, Martinelli V, Pereira C, Scotti G, Comi C et al. Transitional progressive multiple sclerosis: MRI and MTI findings. Acta Neurol Scand 1995; 92: 178–182.
Galimberti D, Scalabrini D, Fenoglio C, De Riz M, Comi C, Venturelli E et al. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis. J Neurol Sci 2008a; 267: 86–90.
Galimberti D, Fenoglio C, Comi C, Scalabrini D, De Riz M, Leone M et al. MDC/CCL22 intrathecal levels in patients with multiple sclerosis. Mult Scler 2008b; 14: 547–549.
De Riz M, Galimberti D, Fenoglio C, Piccio LM, Scalabrini D, Venturelli E et al. Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes. Neurosci Lett 2010; 469: 234–236.
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for MS. Ann Neurol 2001; 50: 121–127.
Lublin F, Reingold SC . Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 50: 423–428.
Fenoglio C, Galimberti D, Ban M, Maranian M, Scalabrini D, Venturelli E et al. SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis. Neurosci Lett 2006; 394: 92–96.
Acknowledgements
This work was supported by grants from Bayer, IRCCS Ospedale Maggiore Policlinico (Milano) to DG and CC, Italian Ministry of Health to FMB (Giovani Ricercatori 2007, D.lgs 502/92), Monzino Foundation, Ing. Cesare Cusan and Regione Piemonte, Ricerca Sanitaria Finalizzata 2007.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Fenoglio, C., Scalabrini, D., Esposito, F. et al. Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males. Genes Immun 11, 497–503 (2010). https://doi.org/10.1038/gene.2010.18
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2010.18
Keywords
This article is cited by
-
Progranulin deficiency results in sex-dependent alterations in microglia in response to demyelination
Acta Neuropathologica (2023)